50K sq.ft.
Modular GMP Production Space
Innovation for Lifesaving Biologics
Canadian-Grown Biomanufacturing with Global Impact
CPPB Inc. provides sovereign, sustainable, and accessible biologics production backed by GMP excellence, advanced analytics, and resilient supply chains for Canada and international partners.
Health Canada Licensed
GMP Compliant
BBB Accredited
ISO 9001
18+
Biologics in Active Development
24/7
National Pandemic Readiness
99.8%
Batch Release Reliability
R&D Pipeline
Accelerated Development from Discovery to Commercialization
Our integrated teams deliver agile development cycles for vaccines, monoclonal antibodies, and cell therapies with transparent data sharing and regulatory alignment across every milestone.
Discovery
Platform screening, antigen design, and AI-driven candidate selection supported by bioinformatics labs.
- AI-assisted lead optimization
- In-silico immunogenicity modeling
- Sustainability scorecard for each program
Preclinical
GLP-compliant studies and toxicology with rapid data visualization and traceability.
- Digital twin bioreactors
- Integrated LIMS reporting
- Indigenous community engagement advisory
Clinical
Scalable processes ready for Phase I-III trials with end-to-end GMP production and analytics.
- Adaptive trial design support
- Clinical supply chain integration
- Patient-centric monitoring tools
Commercial
Launch readiness with QC release, serialization, and global distribution compliance.
- Regulatory dossier assembly
- Export-ready cold chain logistics
- Lifecycle management analytics
Product Centre
Biologics Portfolio Tailored to Global Health Needs
Explore our modular manufacturing capabilities for vaccines, advanced therapeutics, and pandemic countermeasures.
mRNA & LNP Vaccines
Flexible lipid nanoparticle platforms ready for rapid antigen swaps and pandemic surge production.
- 50L to 2000L bioreactors
- Cold chain down to -80°C
- Health Canada emergency use support
Monoclonal Antibodies
High-yield CHO processes with quality-by-design controls and automated filtration platforms.
- Integrated PAT analytics
- Viral clearance validation
- Customizable fill-finish suites
Cell & Gene Therapies
Cleanroom pods and closed systems optimized for autologous and allogeneic therapies.
- Grade B/A environments
- Vector production support
- Regenerative medicine expertise
Biodefense Solutions
Strategic stockpile support, rapid response playbooks, and government partnership frameworks.
- 24-hour response protocols
- Integrated national distribution
- Secure procurement channels
Scientific Innovation
Immersive Science, Data-Driven Decisions
CPPB integrates digital labs, AR-supported training, and predictive modeling to de-risk biologics manufacturing.
3D Molecular Studio
Interactive molecular visualization showcases structure-function relationships and stability profiles for partners.
Book a live demoDigital Process Twin
Real-time dashboards mirror production suites, forecasting yields and environmental conditions with machine learning.
- Predictive deviation alerts
- Energy usage monitoring for sustainability
- Automated CFR Part 11 compliant audit trails
Immersive Training Lab
VR onboarding accelerates technician readiness while meeting bilingual training requirements across Canada.
- Scenario-based aseptic training
- Remote audit participation
- Accessibility-first UI design
Clinical Trials
Patient-Centred Clinical Programs
Our clinical operations team supports inclusive recruitment, ethics compliance, and digital patient engagement across Canada.
National Trial Network
Partnered with 35+ Canadian hospitals and Indigenous health organizations to deliver equitable access.
Remote Monitoring
Telehealth integrations and wearable device data ensure continuous safety reporting and patient comfort.
Regulatory Navigation
Dedicated regulatory science team liaises with Health Canada, FDA, and EMA for synchronized submissions.
COVID-19 Response
Rapid Response Hub for Emerging Pathogens
CPPB maintains a permanent pandemic preparedness division delivering 30-day scale-up windows, variant surveillance, and coordinated reporting with the Public Health Agency of Canada.
- Integrated genomic sequencing for variant watchlists
- Strategic stockpiles with the Canadian Pandemic Plan
- Community outreach in English, French, Cree, and Inuktitut
30 days
Rapid vaccine scale-up commitment
12
Provincial MOUs for emergency deployment
4
Dedicated BSL-3 research suites
News & Insights
Latest Developments from CPPB
Stay informed with milestones, regulatory updates, and community outreach stories.
March 12, 2025
CPPB Opens New mRNA Innovation Centre in Montréal
The new centre expands lipid nanoparticle research and offers collaborative space for Canadian start-ups.
Schedule a visitFebruary 26, 2025
Phase II RSV Vaccine Achieves Primary Endpoints
Interim analysis confirms strong immunogenicity with favourable safety profile across pediatric cohorts.
Review trial dataJanuary 15, 2025
CPPB Launches Indigenous Health Partnership Program
New program supports culturally grounded clinical research and accessible vaccine education.
Learn about co-developmentInvestors
Transparent Governance & Sustainable Growth
CPPB ensures rigorous oversight, ESG reporting, and resilient revenue streams through public-private partnerships.
2024 ESG Highlights
- Net-zero energy roadmap aligned with Canadian Net-Zero Emissions Accountability Act
- 54% renewable energy usage across facilities
- 75% local procurement with SMB prioritization
Financial Snapshot
- Year-over-year revenue growth: 28%
- Active strategic alliances: 22
- Capital reinvestment in innovation: 18%
Governance
- Independent board with science and public policy leadership
- Quarterly stakeholder transparency reports
- Data privacy certified under Canada’s PIPEDA requirements
Contact CPPB
Connect with Our Experts
We welcome collaboration with innovators, government partners, and health leaders across Canada and worldwide.
Centre de Production de Produits Biologiques (CPPB) Inc.
6120 Avenue Royalmount
Montréal, Québec H4P 2R3
Canada
Email: connect@cppb.ca
Phone: +1 (514) 550-1234